Xiamen
688278.SSXiamen Amoytop Biotech Co., Ltd. Price (688278.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
405,437,526
(0.3349)%Revenue and Profitability
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 280,370,520 | 323,081,460 | 448,282,685 | 729,666,393 | 793,934,304 | 1,132,227,709 | 1,526,905,123 | 2,100,322,880 |
| Net Income | 29,314,080 | 5,168,602 | 16,002,935 | 64,293,940 | 116,569,580 | 181,200,959 | 287,019,921 | 555,449,411 |
| FCF USD | -44,604,897 | -38,296,681 | 74,546,477 | 78,475,239 | -26,201,967 | 43,854,586 | 143,992,282 | 223,639,601 |
| OCF USD | 42,427,163 | -11,405,318 | 89,146,935 | 123,301,259 | 92,608,250 | 234,781,023 | 363,160,688 | 512,100,798 |
Financial Health - DEBT
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.16 | 0.05 | 0.02 | 0.01 |
| D/E | 0.18 | 0.17 | 0.14 | 0.11 | 0.02 | 0.02 | 0.01 | 0.00 |
| CA/CL | 2.28 | 2.49 | 2.87 | 2.95 | 6.72 | 4.71 | 3.57 | 3.32 |
| TA/TL | 3.91 | 4.14 | 3.39 | 3.49 | 6.20 | 5.42 | 4.90 | 4.91 |
| Total Debt | 88,220,705 | 80,000,000 | 70,000,000 | 60,091,712 | 18,917,582 | 25,164,136 | 9,742,189 | 7,924,019 |
Management Performance
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ROIC | 4.49% | 1.13% | 6.01% | 11.73% | 12.09% | 16.64% | 21.81% | 30.27% |
| ROE | 6.13% | 1.07% | 3.21% | 11.41% | 11.65% | 15.60% | 20.39% | 29.60% |
| ROA | 0.00% | 0.81% | 2.26% | 8.14% | 9.77% | 12.72% | 16.23% | 23.58% |
| NM % | 10.46% | 1.60% | 3.57% | 8.81% | 14.68% | 16.00% | 18.80% | 26.45% |
| FCF / R% | 0.00% | -11.85% | 16.63% | 10.75% | -3.30% | 3.87% | 9.43% | 10.65% |
| FCF / NI% | -152.16% | -740.95% | 465.83% | 122.06% | -22.48% | 24.20% | 50.17% | 40.26% |
| Operating Margin (OM) | 0.00 | 0.00 | 0.03 | 0.10 | 0.21 | 0.28 | 0.35 | 0.45 |
Per Share
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| EPS | 0.09 | 0.01 | 0.04 | 0.16 | 0.29 | 0.45 | 0.71 | 1.37 |
| SPS | 0.86 | 0.63 | 1.12 | 1.79 | 1.95 | 2.78 | 3.75 | 5.18 |
| OCPS | 0.13 | -0.02 | 0.22 | 0.30 | 0.23 | 0.58 | 0.89 | 1.26 |
| FCPS | -0.14 | -0.07 | 0.19 | 0.19 | -0.06 | 0.11 | 0.35 | 0.55 |
| BVPS | 1.47 | 0.93 | 1.25 | 1.39 | 2.46 | 2.85 | 3.46 | 4.63 |
Per Share - CAGR
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.09 | 0.01 | 0.04 | 0.16 | 0.29 | 0.45 | 0.71 | 1.37 |
| CAGR-SPS | 0.86 | 0.63 | 1.12 | 1.79 | 1.95 | 2.78 | 3.75 | 5.18 |
| CAGR-OCPS | 0.13 | -0.02 | 0.22 | 0.30 | 0.23 | 0.58 | 0.89 | 1.26 |
| CAGR-FCPS | -0.14 | -0.07 | 0.19 | 0.19 | -0.06 | 0.11 | 0.35 | 0.55 |
| CAGR-BVPS | 1.47 | 0.93 | 1.25 | 1.39 | 2.46 | 2.85 | 3.46 | 4.63 |